Chemistry:Keverprazan
From HandWiki
Keverprazan is a drug for the treatment of duodenal ulcers, gastroesophageal reflux disease (GERD), and H. pylori eradication. It is approved for clinical use in China.[1][2]
References
- ↑ "Fosun Pharma and Carephar Enter into a Global Collaboration to Co-develop and Exclusively Commercialize China's First Self-Developed P-CAB Product Keverprazan Hydrochloride". fosunpharma.com. 19 September 2022. https://www.fosunpharma.com/en/content/details37_11894.html.
- ↑ "Keverprazan Hydrochloride: First Approval". Drugs 83 (7): 639–643. May 2023. doi:10.1007/s40265-023-01865-w. PMID 37074491. https://figshare.com/articles/online_resource/Keverprazan_Hydrochloride_First_Approval/22392319.
 |  |
